 |
|
|
| |
The relationship between sustained virological response and plasma concentrations of faldaprevir or BI 207127 in HCV GT-1-infected patients in SOUND-C2
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Stephen Olson,1 Kyle Baron,2 Matthew Riggs,2 Wulf O Böcher,3 Federico J Mensa1
1Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Metrum Research Group LLC, Tariffville, CT, USA; 3Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
|
| |
|
|
|
|
|
